HALO 2023 Q2
Halozyme Therapeutics (HALO) is expected to report qtrly profits (EPS) and revenues:
Profits Estimates: $0.50 vs. $0.47 = +6%
Revenue Est: +54%
Halozyme Therapeutics (HALO) is expected to report qtrly profits (EPS) and revenues:
Profits Estimates: $0.50 vs. $0.47 = +6%
Revenue Est: +54%